Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP212521.RAYlvcx92UlzgrT--0l-v8-qjGGfoSU8bk6-dfn-eRMK4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP212521.RAYlvcx92UlzgrT--0l-v8-qjGGfoSU8bk6-dfn-eRMK4130_assertion type Assertion NP212521.RAYlvcx92UlzgrT--0l-v8-qjGGfoSU8bk6-dfn-eRMK4130_head.
- NP212521.RAYlvcx92UlzgrT--0l-v8-qjGGfoSU8bk6-dfn-eRMK4130_assertion description "[RARbeta, p16, and MGMT genes showed the highest incidences of methylation in premalignant and invasive carcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP212521.RAYlvcx92UlzgrT--0l-v8-qjGGfoSU8bk6-dfn-eRMK4130_provenance.
- NP212521.RAYlvcx92UlzgrT--0l-v8-qjGGfoSU8bk6-dfn-eRMK4130_assertion evidence source_evidence_literature NP212521.RAYlvcx92UlzgrT--0l-v8-qjGGfoSU8bk6-dfn-eRMK4130_provenance.
- NP212521.RAYlvcx92UlzgrT--0l-v8-qjGGfoSU8bk6-dfn-eRMK4130_assertion SIO_000772 15173091 NP212521.RAYlvcx92UlzgrT--0l-v8-qjGGfoSU8bk6-dfn-eRMK4130_provenance.
- NP212521.RAYlvcx92UlzgrT--0l-v8-qjGGfoSU8bk6-dfn-eRMK4130_assertion wasDerivedFrom befree-20140225 NP212521.RAYlvcx92UlzgrT--0l-v8-qjGGfoSU8bk6-dfn-eRMK4130_provenance.
- NP212521.RAYlvcx92UlzgrT--0l-v8-qjGGfoSU8bk6-dfn-eRMK4130_assertion wasGeneratedBy ECO_0000203 NP212521.RAYlvcx92UlzgrT--0l-v8-qjGGfoSU8bk6-dfn-eRMK4130_provenance.